Abstract:Tumor necrosis factor alpha (TNF-alpha) is a pleiotropic cytokine with diverse biological actions. Studies originally identified TNF-alpha as a systemic mediator of endotoxemic shock, cachexia, and tumor regression. We now recognize that TNF-alpha is a member of a large family of proteins, including Fas ligand, whose actions are primarily paracrine in nature, and serve to regulate both cell proliferation and apoptotic death. Although clinical trials with TNF-alpha inhibitors in sepsis syndrome have been disappointing to date, and TNF-alpha administration has not proven widely successful as an antineoplastic agent, preliminary successes with TNF-alpha inhibition have been recently reported in more chronic inflammatory diseases, including rheumatoid arthritis and ulcerative colitis. The recent description of the TNF-alpha converting enzyme responsible for the processing of cell-associated to secreted TNF-alpha has opened a new therapeutic avenue to address inflammatory diseases dependent on the release of 17-kd secreted TNF-alpha. Similarly, inhibitors of nuclear factor kappa B activation can increase TNF-alpha-mediated apoptosis and have rejuvenated efforts to explore TNF-alpha's antineoplastic potential. The multiple and often conflicting TNF-alpha signaling pathways reveal a diversity to TNF-alpha's actions not fully appreciated in the past. Such investigations have opened a number of novel therapeutic interventions to either inhibit or potentiate the actions of TNF-alpha during surgical injury or acute inflammation.

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

Selective Targeting of TNF Receptors as a Novel Therapeutic Approach

TNF, Cell Death and Inflammation

Death by TNF: a road to inflammation

Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation

Research advance of selective inhibitor of tumornecrosis factor receptor

TNF in the liver: targeting a central player in inflammation

Editorial: Targeting TNF/TNFR signaling pathways.

TNF receptors: Structure-function relationships and therapeutic targeting strategies

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

TNF in Human Tuberculosis: A Double-Edged Sword

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology

Tnf-R1 Signaling: A Beautiful Pathway

Biologics targeted at TNF: design, production and challenges.

Reverse Genetics Applied to Immunobiology of Tumor Necrosis Factor, a Multifunctional Cytokine

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy

Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications

Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.

Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy

Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer